Schedule 13D ownership disclosure
Cancer Genetics Inc
Security class unavailable · CUSIP: 13739U203
Event date: 2020-10-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 155,542
- Percent of class
- 3.8200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001513162-20-000226
- Form type
- SC 13D
- Filer
- Vyant Bio, Inc.
- CIK
- CIK 1349929
- Filed
- Nov 09, 2020
- Reporting period
- Oct 29, 2020
- Description
- Schedule 13D beneficial ownership